Compounds derived from 1,4-diazabicyclo [3.2.2] nonanos as neural nicotinic acetylcholine receptor ligands； Pharmaceutical composition that comprises； and its use for the treatment of inflammatory diseases and disorders associated with dysfunction of the central nervous system.
The present invention relates to compounds that bind to and modulate the activity of neuronal nicotinic acetylcholine receptors, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders, including inflammatory diseases and diseases associated with dysfunction of the central nervous system (CNS).COMPUESTOS DERIVADOS DE 1,4-DIAZABICICLO[3.2.2]NONANOS, COMO LIGANDOS DE RECEPTORES NICOTINICOS NEURONALES DE ACETILCOLINA； COMPOSICION FARMACEUTICA QUE LOS COMPRENDE； Y SU USO PARA EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS Y ENFERMEDADES ASOCIADAS A LA DISFUNCION DEL SISTEMA NERVIOSO CENTRAL.
